Real-world occurrence, therapy, and outcome of patients with class 2 or 3 BRAF compared with class 1 BRAF-mutated cancers
2024 · ESMO Real World Data and Digital Oncology · 2 citations
https://doi.org/10.1016/j.esmorw.2024.100075
B
Benedict Gosztonyi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
14
Citations
2
h-index
0
i10-index
Benedict Gosztonyi is an academic researcher from University Hospital of Zurich. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Cancer Genomics and Diagnostics & Melanoma and MAPK Pathways. The author has an h-index of 2, co-authored 8 publications.
ORCID: 0000-0003-2215-7220Papers by this author
worksPrecision Oncology Program (POP), an observational study using real-world data and imaging mass cytometry to explore decision support for the Molecular Tumor Board: study protocol
2025 · BMJ Open · 1 citations
https://doi.org/10.1136/bmjopen-2024-096591
Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer – results from the Tumor Profiler Melanoma project
2025 · npj Precision Oncology · 1 citations
https://doi.org/10.1038/s41698-025-01229-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat